CN106372430A - Method for processing therapeutic scheme information - Google Patents
Method for processing therapeutic scheme information Download PDFInfo
- Publication number
- CN106372430A CN106372430A CN201610799219.1A CN201610799219A CN106372430A CN 106372430 A CN106372430 A CN 106372430A CN 201610799219 A CN201610799219 A CN 201610799219A CN 106372430 A CN106372430 A CN 106372430A
- Authority
- CN
- China
- Prior art keywords
- information
- rule set
- therapeutic scheme
- scheme information
- scheme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention relates to a method for processing therapeutic scheme information, which comprises: receiving the therapeutic scheme information; judging whether the therapeutic scheme accords with medical insurance rule sets, wherein the medical insurance rule sets comprise a reasonable drug application rule set and a disease diagnosis and treatment scheme rule set; if the therapeutic scheme accords with the medical insurance rule sets comprising the reasonable drug application rule set and the disease diagnosis and treatment scheme rule set, outputting result information representing that the therapeutic scheme information is reasonable. According to the method for processing the therapeutic scheme information, which is provided by the invention, by judging whether the therapeutic scheme information accords with the reasonable drug application rule set and the disease diagnosis and treatment scheme rule set, uneconomic and unreasonable treatment schemes are found, so that rapid and accurate processing on the therapeutic scheme information is implemented.
Description
Technical field
The present invention relates to a kind of information processing method, more particularly, to a kind of processing method of therapeutic scheme information.
Background technology
Medical services involve national all citizens, are one of public topics that the public pays special attention to, medical care expenses
Unreasonable growth, is also one of whether harmonious key issue of impact doctor-patient relationship, but the reasonability of medical expense is divided
Analysis method currently there are no to be set up it is therefore desirable to set up a kind of method finding uneconomical rational therapy scheme, and it is carried out
In thing, information-based intervention or post-project evaluating, reach the purpose of medical insurance control expense.
Content of the invention
The purpose of the present invention is the defect for prior art, provides a kind of processing method of therapeutic scheme information, thus
Realize the process fast and accurately to therapeutic scheme information.
For achieving the above object, the invention provides a kind of processing method of therapeutic scheme information, comprising:
Step 1, receives therapeutic scheme information；
Step 2, judges whether described therapeutic scheme information meets medical care insurance rule set, described medical care insurance rule set bag
Include rational use of drug rule set and disease treatment scheme rule set；
Step 3, if described therapeutic scheme information do not meet rational use of drug rule set in medical care insurance rule set and/or
Disease treatment scheme rule set, then export the unreasonable object information of described therapeutic scheme information.
Further, described step 1 specifically includes: receives the therapeutic scheme information in out-patient treatment for the patient.
Further, methods described also includes: when described therapeutic scheme information does not meet rational use of drug rule set, or not
When meeting disease treatment scheme rule set, export information warning in first terminal.
Further, described step 1 specifically includes: receives therapeutic scheme information when in hospital for the patient.
Further, methods described also includes: when described therapeutic scheme information does not meet rational use of drug rule set,
One terminal exports the first information warning；When described therapeutic scheme information does not meet disease treatment scheme rule set, second eventually
End output the second information warning.
Further, when the rational use of drug rule set in described step 2 includes the usage and dosage information of medicine, administration
Machine information, route of administration information, interaction information, special population such as motherhood information, suckling information and old people's taboo information.
Further, the disease treatment scheme rule set in described step 2 includes patient's drug administration information and disease outcome
Information.
The processing method of the therapeutic scheme information that the present invention provides, by judging whether therapeutic scheme information meets reasonable use
Medicine rule to find uneconomical rational therapy scheme with disease treatment scheme rule, thus realizing quick to therapeutic scheme information
Process with accurate.
Brief description
Fig. 1 is the process flow figure of therapeutic scheme information of the present invention.
Specific embodiment
Below by drawings and Examples, technical scheme is described in further detail.
The technical process of the present invention includes the discovery of uneconomical rational therapeutic scheme and uneconomical rational therapeutic scheme
Process.Mainly pass through medical care insurance rule set (including rational use of drug rule set and disease treatment scheme rule set) to complete.
Fig. 1 be therapeutic scheme information of the present invention processing method flow chart, as illustrated, the present invention specifically include as follows
Step:
Step 101, receives therapeutic scheme information.
Therapeutic scheme information include types of drugs combination, drug administration dosage, administration frequency, drug administration approach, to
Medication journey, the order of administration of different pharmaceutical breed combination and dosing interval information.
Therapeutic scheme information (being also disease dosage regimen information) refers to: in clinical treatment, in order to reach rational use of drug
Purpose, the concrete condition according to patient and the pharmacodynamicss of medicine and pharmacokineticss feature proposed treatment (include types of drugs combination,
Drug administration dosage, administration frequency, drug administration approach, drug delivery regimen, the order of administration of different pharmaceutical breed combination and administration
Interval etc.) plan information.
Step 102, judges whether described therapeutic scheme information meets medical care insurance rule set, described medical care insurance rule set
Including rational use of drug rule set and disease treatment scheme rule set.
Specifically, medical care insurance rule collecting system is based on the therapeutic scheme of economical rationality (cost performance is high), is right
The therapeutic scheme of economical rationality carries out the regular collection after symbolization.All therapeutic scheme information are through medical care insurance rule set system
During system, system simulates the critical thinking process of people by intellgence reasoning machine, according to the logical judgment rule set up in system, simulation
The critical thinking mode of clinical rational drug use expert, using patient demographic, disease information, operation/operation information, administration
The results such as information, judge whether therapeutic scheme meets (including operation/operation scheme, therapeutic regimen) requirement of rule.
The therapeutic scheme of economical rationality is by veteran medical science and pharmacy, health economics expert according to up-to-date both at home and abroad
Health economics Research Literature and treatment guidelines and evidence-based medicine EBM foundation, after comparing, use for reference, screening, for certain disease
And the condition such as patient population information forms the therapeutic scheme of economical rationality (cost performance is high), stored in the form of rule set.
Wherein, medical care insurance rule set includes rational use of drug rule set and disease treatment scheme rule set.Rational use of drug is advised
Then concentrate and include the usage and dosage information of medicine, delivery time information, route of administration information, interaction information, special population
As motherhood information, suckling information and old people avoid information；Disease treatment scheme rule set includes patient's drug administration information and disease
Sick object information.
Step 103, if described therapeutic scheme information do not meet rational use of drug rule set in medical care insurance rule set and/
Or disease treatment scheme rule set, then export the unreasonable object information of described therapeutic scheme information.
When therapeutic scheme information does not meet rational use of drug rule set and/or disease treatment scheme rule set, then explanation should
Therapeutic scheme is uneconomical rational therapeutic scheme, exports unreasonable object information.
In addition, also including two kinds of situations in a step 101 it is simply that therapeutic scheme information is outpatient service or is in hospital, specifically such as
Under:
The first situation, receives the therapeutic scheme information in out-patient treatment for the patient.
Therapeutic scheme information when patient is in out-patient treatment does not meet rational use of drug rule set, or does not meet disease and examine
During treatment scheme rule set, export information warning in first terminal (doctor's terminal).
Specifically, for out-patient treatment scheme information, if rational use of drug rule set or disease treatment scheme can not be met
The requirement of rule set, then can propose to intervene with terminal in doctor in the form of information warning, enter in acting and intervene.
Second situation, receives therapeutic scheme information when in hospital for the patient.
Therapeutic scheme information when patient is in hospital does not meet rational use of drug rule set, and in first terminal, (doctor is eventually
End) output the first information warning；When therapeutic scheme information when patient is in hospital does not meet disease treatment scheme rule set,
Second terminal (insurance company's terminal) exports the second information warning.
Specifically, in hospital when therapeutic scheme information, if rational use of drug rule set or disease treatment can not be met
The requirement of scheme rule set, then can propose to intervene in doctor terminal, simultaneity factor backstage can record automatically in the form of information warning
These information lower, result are given insurance company end, insurance company end can carry out retrospection appraisal.
Illustrate:
Calcipotriol Ointment indication is psoriasises, if to not being psoriatic patient using being exactly a uneconomical conjunction
The therapeutic scheme of reason.
Doctor has opened Calcipotriol Ointment to non-psoriatic patient, is judged by medical care insurance rule set, sends out
Now this is an irrational therapeutic scheme, can propose information warning in doctor terminal, reminds doctor that " this Calcipotriol Ointment uses
Unreasonable, only limit psoriasises use ".If the unmodified prescription of doctor, it is uneconomical rationally that system background records this automatically
Treatment information, insurance company end can view this information.
According to treatment guidelines, the First-line chemotherapy scheme that treatment late period non-squama nonsmall-cell lung cancer is commonly used at present has pemetrexed
+ platinum class, gemcitabine+platinum class, docetaxel+platinum class, according to pharmacoeconomicss document, docetaxel+platinum class are 3 kinds of chemotherapy sides
The therapeutic scheme of most superiority of effectiveness in case；If therefore give late period non-squama nonsmall-cell lung cancer use pemetrexed+platinum class,
Gemcitabine+platinum class are uneconomic therapeutic schemes.
Doctor issues pemetrexed+platinum class or the two kinds of changes of gemcitabine+platinum class to late period non-squama Patients with Non-small-cell Lung
Treatment scheme, is judged by medical care insurance rule set, finds that this is a uneconomic therapeutic scheme, then system background from
Move and record this uneconomic treatment information, insurance company end can view this information.
The processing method of the therapeutic scheme information that the present invention provides, by judging whether therapeutic scheme information meets reasonable use
Medicine rule to find uneconomical rational therapy scheme with disease treatment scheme rule, thus realizing quick to therapeutic scheme information
Process with accurate.
Professional should further appreciate that, each example describing in conjunction with the embodiments described herein
Unit and algorithm steps, can be hard in order to clearly demonstrate with electronic hardware, computer software or the two be implemented in combination in
Part and the interchangeability of software, generally describe composition and the step of each example in the above description according to function.
These functions to be executed with hardware or software mode actually, the application-specific depending on technical scheme and design constraint.
Professional and technical personnel can use different methods to each specific application realize described function, but this realization
It is not considered that it is beyond the scope of this invention.
The step of the method in conjunction with the embodiments described herein description or algorithm can be with hardware, computing device
Software module, or the combination of the two is implementing.Software module can be placed in random access memory (ram), internal memory, read only memory
(rom), electrically programmable rom, electrically erasable rom, depositor, hard disk, moveable magnetic disc, cd-rom or technical field
In interior known any other form of storage medium.
Above-described specific embodiment, has been carried out to the purpose of the present invention, technical scheme and beneficial effect further
Describe in detail, be should be understood that the specific embodiment that the foregoing is only the present invention, be not intended to limit the present invention
Protection domain, all any modification, equivalent substitution and improvement within the spirit and principles in the present invention, done etc., all should comprise
Within protection scope of the present invention.
Claims (7)
1. a kind of processing method of therapeutic scheme information is it is characterised in that methods described includes:
Step 1, receives therapeutic scheme information；
Step 2, judges whether described therapeutic scheme information meets medical care insurance rule set, and described medical care insurance rule set includes closing
Reason medication rule set and disease treatment scheme rule set；
Step 3, if described therapeutic scheme information does not meet rational use of drug rule set and/or disease in medical care insurance rule set
Diagnosis and treatment scheme rule set, then export the unreasonable object information of described therapeutic scheme information.
2. method according to claim 1 is it is characterised in that described step 1 specifically includes: receives patient in out-patient treatment
When therapeutic scheme information.
3. method according to claim 2 is it is characterised in that methods described also includes: when described therapeutic scheme information not
When meeting rational use of drug rule set, or not meeting disease treatment scheme rule set, export information warning in first terminal.
4. method according to claim 1 is it is characterised in that described step 1 specifically includes: receives patient when in hospital
Therapeutic scheme information.
5. method according to claim 4 is it is characterised in that methods described also includes: when described therapeutic scheme information not
Meet rational use of drug rule set, export the first information warning in first terminal；Examine when described therapeutic scheme information does not meet disease
During treatment scheme rule set, export the second information warning in second terminal.
6. method according to claim 1 is it is characterised in that the rational use of drug rule set in described step 2 includes medicine
The usage and dosage information of thing, delivery time information, route of administration information, interaction information, special population such as motherhood information, the food in one's mouth
Newborn information and old people's taboo information.
7. method according to claim 1 is it is characterised in that wrap in disease treatment scheme rule set in described step 2
Include patient's drug administration information and disease outcome information.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610799219.1A CN106372430A (en) | 2016-08-31 | 2016-08-31 | Method for processing therapeutic scheme information |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610799219.1A CN106372430A (en) | 2016-08-31 | 2016-08-31 | Method for processing therapeutic scheme information |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106372430A true CN106372430A (en) | 2017-02-01 |
Family
ID=57900524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610799219.1A Pending CN106372430A (en) | 2016-08-31 | 2016-08-31 | Method for processing therapeutic scheme information |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106372430A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107451400A (en) * | 2017-07-11 | 2017-12-08 | 武汉金豆医疗数据科技有限公司 | A kind of medical act monitoring method and system |
| CN111223546A (en) * | 2020-02-13 | 2020-06-02 | 曹庆恒 | Method, system and equipment for intelligently auditing treatment scheme |
| CN111223543A (en) * | 2020-02-13 | 2020-06-02 | 曹庆恒 | Method, system and equipment for intelligently guiding treatment scheme |
| WO2024098513A1 (en) * | 2022-11-07 | 2024-05-16 | 上海维小美网络科技有限公司 | Diagnosis and treatment record compliance management method for oral cavity management system |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102004863A (en) * | 2010-12-15 | 2011-04-06 | 中国人民解放军第四军医大学 | Clinical safe and reasonable administration decision supporting method |
| CN105760705A (en) * | 2016-05-20 | 2016-07-13 | 陕西科技大学 | Medical diagnosis system based on big data |
-
2016
- 2016-08-31 CN CN201610799219.1A patent/CN106372430A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102004863A (en) * | 2010-12-15 | 2011-04-06 | 中国人民解放军第四军医大学 | Clinical safe and reasonable administration decision supporting method |
| CN105760705A (en) * | 2016-05-20 | 2016-07-13 | 陕西科技大学 | Medical diagnosis system based on big data |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107451400A (en) * | 2017-07-11 | 2017-12-08 | 武汉金豆医疗数据科技有限公司 | A kind of medical act monitoring method and system |
| CN111223546A (en) * | 2020-02-13 | 2020-06-02 | 曹庆恒 | Method, system and equipment for intelligently auditing treatment scheme |
| CN111223543A (en) * | 2020-02-13 | 2020-06-02 | 曹庆恒 | Method, system and equipment for intelligently guiding treatment scheme |
| WO2024098513A1 (en) * | 2022-11-07 | 2024-05-16 | 上海维小美网络科技有限公司 | Diagnosis and treatment record compliance management method for oral cavity management system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ferreira et al. | Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities | |
| Torrance et al. | Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: a primary care data linkage study | |
| Lassi et al. | Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months | |
| Laugsand et al. | Inadequate symptom control in advanced cancer patients across Europe | |
| CN102737165B (en) | Clinical medication decision support system | |
| CN106327395A (en) | Medical expense information processing method | |
| Suhaj et al. | Effectiveness of clinical pharmacist intervention on health‐related quality of life in chronic obstructive pulmonary disorder patients–a randomized controlled study | |
| CN106372430A (en) | Method for processing therapeutic scheme information | |
| Carson et al. | Medicaid databases | |
| Blais et al. | Validity of congenital malformation diagnostic codes recorded in Quebec's administrative databases | |
| CN106407662A (en) | Medication information processing method based on warning information | |
| CN107180157A (en) | Medical information processing method | |
| CN106383993B (en) | The processing method of medical information | |
| Rinner et al. | Improving the informational continuity of care in diabetes mellitus treatment with a nationwide Shared EHR system: Estimates from Austrian claims data | |
| Säfholm et al. | Medication errors in primary health care records; a cross-sectional study in Southern Sweden | |
| Bekker et al. | Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy | |
| CN102722645A (en) | Construction method and management system for use regulation knowledge base of clinical antibacterial medicines | |
| Meyer et al. | How reliable are patient-completed medication reconciliation forms compared with pharmacy lists? | |
| Price et al. | Methadone for pain and the risk of adverse cardiac outcomes | |
| Zarif-Yeganeh et al. | Incidence of medication discrepancies and its predicting factors in emergency department | |
| Carney | Medication accuracy and general practitioner referral letters | |
| Ranapurwala et al. | Impact of Iowa’s prescription monitoring program on opioid pain reliever prescribing patterns: an interrupted time series study 2003–2014 | |
| CN106971083A (en) | Medication information processing method based on test rating | |
| Christensen et al. | Identifying the “blip on the radar screen”: leveraging big data in defining drug safety and efficacy in pediatric practice | |
| CN107066826A (en) | Medication information processing method based on test rating |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |
|
| RJ01 | Rejection of invention patent application after publication |